-
Determination of eprosartan mesylate and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods.
Journal of chromatographic science 20120901
-
Antihypertensive effects and safety of eprosartan: a meta-analysis of randomized controlled trials.
European journal of clinical pharmacology 20120201
-
Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) study.
Journal of clinical hypertension (Greenwich, Conn.) 20120201
-
[The use of melatonin for correction of sleep disturbances in assembly-line shift workers with arterial hypertension].
Klinicheskaia meditsina 20120101
-
Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study.
Vascular health and risk management 20120101
-
The effect of eprosartan on reflex sympathetic activation in sodium restricted patients with essential hypertension.
Journal of the American Society of Hypertension : JASH 20110101
-
Liquid chromatographic method for the simultaneous determination of eprosartan and hydrochlorothiazide in tablets and human plasma.
Journal of AOAC International 20110101
-
Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study.
Vascular health and risk management 20110101
-
[Adjustment of antihypertensive therapy to a generic eprosartan preparation. Results of a non-interventional study].
MMW Fortschritte der Medizin 20101014
-
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Advances in therapy 20100601
-
Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction.
European journal of heart failure 20100401
-
Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Biopharmaceutics & drug disposition 20100301
-
Characterization of a novel impurity in bulk drug eprosartan by ESI/MS(n) and NMR.
Journal of pharmaceutical and biomedical analysis 20100205
-
Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.
Cardiovascular drugs and therapy 20100201
-
Development and validation of a high-performance liquid chromatographic method for determination of eprosartan in bulk drug and tablets.
Journal of AOAC International 20100101
-
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20091201
-
Cost-utility analysis of eprosartan compared to enalapril in primary prevention and nitrendipine in secondary prevention in Europe--the HEALTH model.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090901
-
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growth inhibition.
The Journal of pharmacology and experimental therapeutics 20090601
-
Hemodynamic and cardiac effects of chronic eprosartan and moxonidine therapy in stroke-prone spontaneously hypertensive rats.
Hypertension (Dallas, Tex. : 1979) 20090501
-
Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
Expert review of cardiovascular therapy 20090501
-
Superoxide dismutase and catalase anti-oxidant activity in leucocyte lysates from hypertensive patients: effects of eprosartan treatment.
Journal of the renin-angiotensin-aldosterone system : JRAAS 20090301
-
Costs of eprosartan versus diuretics for treatment of hypertension in a geriatric population: an observational, open-label, multicentre study.
Drugs & aging 20090101
-
[The use of melaxen in combined therapy of arterial hypertension in subjects occupied in assembly line production].
Klinicheskaia meditsina 20090101
-
Eprosartan: a review of its use in hypertension.
Drugs 20090101
-
Clinical profile of eprosartan: a different angiotensin II receptor blocker.
Cardiovascular & hematological agents in medicinal chemistry 20081001
-
Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Journal of hypertension 20080801
-
Effects of eprosartan on mitochondrial membrane potential and H2O2 levels in leucocytes in hypertension.
Journal of human hypertension 20080701
-
Eprosartan modulates the reflex activation of the sympathetic nervous system in sodium restricted healthy humans.
British journal of clinical pharmacology 20080601
-
Spectral and polarographic determination of eprosartan. Kinetic studies of the oxidation of eprosartan using a platinum electrode.
Die Pharmazie 20080601
-
Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
Hypertension (Dallas, Tex. : 1979) 20080301
-
Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method.
Journal of separation science 20080301
-
Selenosartans: novel selenophene analogues of milfasartan and eprosartan.
Bioorganic & medicinal chemistry letters 20080201
-
Effectiveness of eprosartan in diabetic hypertensive patients.
European journal of internal medicine 20080101
-
Comparison of monotherapy versus combination antihypertensive therapy in elderly patients with essential hypertension.
Angiology 20080101
-
[Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation].
Kardiologiia 20080101
-
[Effect of eprosartan on thrombocytes aggregative capacity in patients with arterial hypertension and metabolic syndrome].
Klinicheskaia meditsina 20080101
-
Eprosartan in the primary prevention of cardiac allograft vascular disease: a double-blind prospectively randomized study using intravascular ultrasound.
The Journal of international medical research 20080101
-
Unique dual mechanism of action of eprosartan: effects on systolic blood pressure, pulse pressure, risk of stroke and cognitive decline.
Expert review of cardiovascular therapy 20071101
-
Introduction: The pharmacological profile of eprosartan--implications for cerebrovascular and cardiovascular risk reduction.
Current medical research and opinion 20071101
-
Angiotensin blockade with eprosartan: vascular and functional implications.
Current medical research and opinion 20071101
-
Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
Current medical research and opinion 20071101
-
Risk reduction by preventing stroke: need for blockade of angiotensin II and catecholamines?
Current medical research and opinion 20071101
-
Pharmacokinetics and urinary excretion of eprosartan in Chinese healthy volunteers of different gender.
Die Pharmazie 20071001
-
An update on non-peptide angiotensin receptor antagonists and related RAAS modulators.
Life sciences 20070802
-
Effects of different AT1-receptor antagonists in the therapy of severe heart failure pretreated with ACE inhibitors.
Acta cardiologica 20070801
-
Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy-resistant hypertensive patients.
Journal of thrombosis and haemostasis : JTH 20070701
-
Determination of eprosartan in human plasma and urine by LC/MS/MS.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615
-
[Role of the renin-angiotensin system on the sympathetic response induced by the cold pressor test in humans].
Investigacion clinica 20070601
-
Small artery structure adapts to vasodilatation rather than to blood pressure during antihypertensive treatment.
Journal of hypertension 20070501
-
Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
Fundamental & clinical pharmacology 20070401
-
Effect of AT(1) angiotensin II receptor antagonists on the sympathetic response to a cold pressor test in healthy volunteers.
American journal of therapeutics 20070101
-
Eprosartan in secondary prevention of stroke: the economic evidence.
Cardiovascular journal of Africa 20070101
-
[The effectiveness of eprosartan in patients with chronic glomerulonephritis].
Klinicheskaia meditsina 20070101
-
[Stress-associated hypertension in the work place: results of the STARLET project].
Deutsche medizinische Wochenschrift (1946) 20061117
-
[Not all antihypertensive agents protect equally well].
MMW Fortschritte der Medizin 20060817
-
Validation of a solid phase extraction-high performance liquid chromatographic method for the determination of eprosartan in human plasma.
Journal of chromatography. A 20060630
-
Effect of eprosartan on the sympathetic response to cold pressor test in healthy volunteers.
Autonomic neuroscience : basic & clinical 20060630
-
Does the MOSES study provide sufficient evidence for Eprosartan against Nitrendipine?
Stroke 20060601
-
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension.
American journal of physiology. Heart and circulatory physiology 20060401
-
Effects of eprosartan on target organ protection.
Vascular health and risk management 20060301
-
Morbidity and mortality after stroke--eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES).
Stroke 20060201
-
MOSES raises questions.
Stroke 20060201
-
Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
American journal of hypertension 20060201
-
Effects of antihypertensive treatment with angiotensin II receptor blockers on lipid profile: an open multi-drug comparison trial.
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20060101
-
[An AT-II blocker in patients with type II diabetes and arterial hypertension].
Klinicheskaia meditsina 20060101
-
Preventing cerebrovascular and cardiovascular events after stroke: eprosartan or nitrendipine?
Nature clinical practice. Neurology 20060101
-
[Effect of eprosartan on psychophysiological functions of drivers with arterial hypertension].
Kardiologiia 20060101
-
Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity.
Diabetes 20051201
-
Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure.
American journal of physiology. Heart and circulatory physiology 20051001
-
Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?
Journal of hypertension 20051001
-
Haemodynamic effects of eprosartan and valsartan in hypertensive patients during isometric and mental stress.
Journal of hypertension 20051001
-
Analysis of recent papers in hypertension. An angiotensin receptor blocker is more effective than a calcium channel blocker in secondary stroke prevention.
Journal of clinical hypertension (Greenwich, Conn.) 20050801
-
Adrenal angiotensin: origin and site of generation.
American journal of hypertension 20050801
-
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).
Stroke 20050601
-
[Effect of a combination of teveten and prestarium in patients with chronic heart failure].
Georgian medical news 20050601
-
Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
International journal of clinical practice 20050401
-
Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
Clinical science (London, England : 1979) 20050201
-
Losartan increases bradykinin levels in hypertensive humans.
Circulation 20050125
-
Eprosartan (Teveten) offers new opportunities to prevent a second stroke.
Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20050101
-
[Cerebral hemodynamics and endothelium function in patients with cerebrovascular pathology treated by teveten].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101
-
Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study.
American journal of nephrology 20050101
-
Eprosartan: a review of its use in the management of hypertension.
Drugs 20050101
-
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
The British journal of ophthalmology 20041201
-
Effect of eprosartan on pulse pressure and blood pressure components in patients with isolated systolic hypertension.
Blood pressure. Supplement 20041201
-
Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.
Journal of the American Society of Nephrology : JASN 20041101
-
New tools, old challenges: the emerging role of angiotensin receptor blockers in the treatment of the systolic hypertension epidemic.
The Canadian journal of cardiology 20041001
-
Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
The Canadian journal of cardiology 20041001
-
The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
The Canadian journal of cardiology 20041001
-
The effect of treatment with eprosartan on pulse pressure: factors predicting response.
The Canadian journal of cardiology 20041001
-
Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Journal of human hypertension 20040901
-
Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension.
American journal of hypertension 20040901
-
Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
Hypertension research : official journal of the Japanese Society of Hypertension 20040701
-
A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
Japanese heart journal 20040701
-
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.
Circulation 20040504
-
[Anti-hypertensive effect of eprosartan in diabetic patients].
Anales de medicina interna (Madrid, Spain : 1984) 20040501
-
Re: Heusser et al: elevation of sympathetic activity by eprosartan in young male subjects.
American journal of hypertension 20040301
-
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
Journal of hypertension 20040301
-
Different prejunctional and postjunctional responses to angiotensin II and AT1-receptor inhibition: influence of maturation.
Journal of cardiovascular pharmacology 20040301
-
Heat shock treatment protects against angiotensin II-induced hypertension and inflammation in aorta.
Cell stress & chaperones 20040301
-
Potential renoprotective effects of the angiotensin receptor blocker eprosartan: a review of preliminary renal studies.
Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101
-
[Effect of eprosartan on microcirculation and blood rheology in patients with hypertensive disease].
Kardiologiia 20040101
-
[Comparison of eprosartan and captopril in left ventricular systolic dysfunction: relation of efficacy to myocardial viability].
Kardiologiia 20040101
-
[Candesartan - a novel AT(1)-angiotensin receptor blocker: peculiarities of pharmacology and experience of use in arterial hypertension].
Kardiologiia 20040101
-
Eprosartan dual action offers clinical benefit for elderly and overweight hypertensives.
Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101
-
Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
Drugs under experimental and clinical research 20040101
-
Teveten (eprosartan) reduces future risk in hypertensive stroke patients.
Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101
-
[Elevation pressure in morning hours in patients with essential hypertension: effect therapy with eprosartan for leading stress tests].
Kardiologiia 20040101
-
Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
Journal of hypertension 20031201
-
Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.
Journal of the renin-angiotensin-aldosterone system : JRAAS 20031201
-
[Dosage equivalents of AT1-receptor antagonists available in Germany].
Deutsche medizinische Wochenschrift (1946) 20031031
-
[Theoretical background of angiotensin II receptor blockade and its features in clinical pharmacology].
Orvosi hetilap 20030907
-
AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain.
Autonomic neuroscience : basic & clinical 20030829
-
Elevation of sympathetic activity by eprosartan in young male subjects.
American journal of hypertension 20030801
-
[When the goal values are more than 20/10 mmHg distant. High blood pressure is to be forced down from two sides immediately].
MMW Fortschritte der Medizin 20030710
-
Cardiology patient page. Angiotensin receptor blockers.
Circulation 20030624
-
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Journal of medicinal chemistry 20030605
-
Pre- and postsynaptic inhibitory potencies of the angiotensin AT1 receptor antagonists eprosartan and candesartan.
European journal of pharmacology 20030523
-
Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
Journal of medicinal chemistry 20030227
-
Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension.
Hypertension (Dallas, Tex. : 1979) 20030201
-
Effects of angiotensin II receptor antagonism on the renal hemodynamic response to cardiovascular stress.
Kidney international 20030201
-
Eprosartan for the treatment of hypertension.
Expert opinion on pharmacotherapy 20030101
-
Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure.
British journal of pharmacology 20030101
-
[Neurocirculatory dystonia (does this disease exist?)].
Kardiologiia 20030101
-
[Antihypertensive treatment with eprosartan mesilate of patients in acute and late periods of ischemic stroke].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101
-
Emerging role of angiotensin II type 1 receptor blockers for the treatment of endothelial dysfunction and vascular inflammation.
The Canadian journal of cardiology 20021201
-
Clinical profile of eprosartan.
Cardiovascular drugs and therapy 20021201
-
Drug points: Dysgeusia and burning mouth syndrome by eprosartan.
BMJ (Clinical research ed.) 20021130
-
Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery.
Journal of cardiovascular pharmacology 20020701
-
Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical N(G), N(G)-dimethylarginine in human essential hypertension.
American journal of hypertension 20020701
-
[Therapy of hypertension. Why the systolic value is decisive].
MMW Fortschritte der Medizin 20020606
-
AT1 blockers and uric acid metabolism: are there relevant differences?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20020601
-
The clinical profile of the angiotensin II receptor blocker eprosartan.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 20020601
-
[Irbesartan: a new possibility in the treatment of hypertension].
Orvosi hetilap 20020526
-
Structure elucidation and conformational properties of eprosartan, a non peptide angiotensin II AT1 antagonist.
Journal of pharmaceutical and biomedical analysis 20020401
-
The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension.
The Journal of pharmacology and experimental therapeutics 20020401
-
Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Kidney international 20020401
-
Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation).
The American journal of cardiology 20020315
-
Brain angiotensinergic mediation of enhanced water consumption in lactating rats.
American journal of physiology. Regulatory, integrative and comparative physiology 20020301
-
Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Journal of human hypertension 20020301
-
Application of capillary zone electrophoresis to the screening of some angiotensin II receptor antagonists.
Electrophoresis 20020101
-
[Significance of pharmacological blockade of angiotensin II type I receptors for correction of abnormal 24-hour blood pressure profile depending on its variability in patients with arterial hypertension stage II].
Terapevticheskii arkhiv 20020101
-
Eprosartan: an angiotensin-II receptor antagonist for the management of hypertension.
Heart disease (Hagerstown, Md.) 20020101
-
Safety and tolerability of eprosartan in combination with hydrochlorothiazide.
Drug safety 20020101
-
[Policy of antihypertensive therapy in arterial hypertension in the elderly. II].
Klinicheskaia meditsina 20020101
-
[Effect of eprosartan on left ventricular diastolic function and cerebral hemodynamics in patients with hypertension].
Kardiologiia 20020101
-
[Metabolic effects of angiotensin-II receptor blockers].
Kardiologiia 20020101
-
Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
Journal of hypertension 20011201
-
Intrarenal angiotensin II: interstitial and cellular levels and site of production.
Kidney international 20011201
-
Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension.
Journal of human hypertension 20011201
-
Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo.
Journal of human hypertension 20011201
-
Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertension.
American journal of hypertension 20011201
-
Angiotensin II antagonists in systolic blood pressure control.
Hospital medicine (London, England : 1998) 20011201
-
Differentiation in the angiotensin II receptor 1 blocker class on autonomic function.
Current hypertension reports 20010901
-
Potential of the angiotensin II receptor 1 blocker eprosartan in the management of patients with hypertension or heart failure.
Current hypertension reports 20010901
-
Issues in hypertension: drug tolerability and special populations.
American journal of hypertension 20010701
-
Pharmacology and clinical efficacy of angiotensin receptor blockers.
American journal of hypertension 20010701
-
Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.
Cardiovascular research 20010601
-
Synthesis and study of a cyclic angiotensin II antagonist analogue reveals the role of pi*--pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists.
Bioorganic & medicinal chemistry 20010601
-
[Antihypertensive drug. Dual action lowers blood pressure more effectively].
MMW Fortschritte der Medizin 20010503
-
ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
American heart journal 20010501
-
Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors.
Naunyn-Schmiedeberg's archives of pharmacology 20010501
-
Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.
Molecular pharmacology 20010401
-
Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications.
Postgraduate medicine 20010401
-
[Stress-induced hypertension. The work site--a cardiovascular risk].
MMW Fortschritte der Medizin 20010315
-
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
Cleveland Clinic journal of medicine 20010301
-
Subcellular localization of angiotensin II in kidney and adrenal.
Journal of hypertension 20010301
-
Central inhibition of AT1receptors by eprosartan--in vitro autoradiography in the brain.
Pharmacological research 20010301
-
[Angiotensin receptor blockers--significance for the therapy of hypertension].
Wiener medizinische Wochenschrift (1946) 20010101
-
Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Current medical research and opinion 20010101
-
Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial.
Blood pressure 20010101
-
Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
Blood pressure 19990101
-
Characterization of [3H]SK&F 108566 as a radioligand for angiotensin type-1 receptor.
Journal of receptor research 19930101
-
Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
The Journal of pharmacology and experimental therapeutics 19920101